S&P 500   4,668.07 (+1.60%)
DOW   35,232.03 (+0.95%)
QQQ   399.79 (+2.20%)
AAPL   160.83 (+2.56%)
MSFT   337.63 (+2.41%)
FB   338.59 (+1.64%)
GOOGL   2,911.57 (+2.39%)
AMZN   3,590.75 (+2.46%)
TSLA   1,139.82 (+5.35%)
NVDA   329.70 (+4.66%)
BABA   131.79 (-1.17%)
NIO   40.00 (+0.03%)
CGC   11.13 (-4.79%)
AMD   159.87 (+3.27%)
GE   98.44 (+0.61%)
MU   84.96 (+1.85%)
T   24.04 (-0.74%)
F   19.86 (+0.56%)
DIS   146.71 (-0.95%)
ACB   6.47 (-4.71%)
AMC   36.70 (-2.47%)
PFE   53.73 (-0.50%)
BA   198.46 (-0.38%)
S&P 500   4,668.07 (+1.60%)
DOW   35,232.03 (+0.95%)
QQQ   399.79 (+2.20%)
AAPL   160.83 (+2.56%)
MSFT   337.63 (+2.41%)
FB   338.59 (+1.64%)
GOOGL   2,911.57 (+2.39%)
AMZN   3,590.75 (+2.46%)
TSLA   1,139.82 (+5.35%)
NVDA   329.70 (+4.66%)
BABA   131.79 (-1.17%)
NIO   40.00 (+0.03%)
CGC   11.13 (-4.79%)
AMD   159.87 (+3.27%)
GE   98.44 (+0.61%)
MU   84.96 (+1.85%)
T   24.04 (-0.74%)
F   19.86 (+0.56%)
DIS   146.71 (-0.95%)
ACB   6.47 (-4.71%)
AMC   36.70 (-2.47%)
PFE   53.73 (-0.50%)
BA   198.46 (-0.38%)
S&P 500   4,668.07 (+1.60%)
DOW   35,232.03 (+0.95%)
QQQ   399.79 (+2.20%)
AAPL   160.83 (+2.56%)
MSFT   337.63 (+2.41%)
FB   338.59 (+1.64%)
GOOGL   2,911.57 (+2.39%)
AMZN   3,590.75 (+2.46%)
TSLA   1,139.82 (+5.35%)
NVDA   329.70 (+4.66%)
BABA   131.79 (-1.17%)
NIO   40.00 (+0.03%)
CGC   11.13 (-4.79%)
AMD   159.87 (+3.27%)
GE   98.44 (+0.61%)
MU   84.96 (+1.85%)
T   24.04 (-0.74%)
F   19.86 (+0.56%)
DIS   146.71 (-0.95%)
ACB   6.47 (-4.71%)
AMC   36.70 (-2.47%)
PFE   53.73 (-0.50%)
BA   198.46 (-0.38%)
S&P 500   4,668.07 (+1.60%)
DOW   35,232.03 (+0.95%)
QQQ   399.79 (+2.20%)
AAPL   160.83 (+2.56%)
MSFT   337.63 (+2.41%)
FB   338.59 (+1.64%)
GOOGL   2,911.57 (+2.39%)
AMZN   3,590.75 (+2.46%)
TSLA   1,139.82 (+5.35%)
NVDA   329.70 (+4.66%)
BABA   131.79 (-1.17%)
NIO   40.00 (+0.03%)
CGC   11.13 (-4.79%)
AMD   159.87 (+3.27%)
GE   98.44 (+0.61%)
MU   84.96 (+1.85%)
T   24.04 (-0.74%)
F   19.86 (+0.56%)
DIS   146.71 (-0.95%)
ACB   6.47 (-4.71%)
AMC   36.70 (-2.47%)
PFE   53.73 (-0.50%)
BA   198.46 (-0.38%)
NASDAQ:MMSI

Merit Medical Systems Stock Forecast, Price & News

$65.57
-0.54 (-0.82%)
(As of 11/29/2021 12:38 PM ET)
Add
Compare
Today's Range
$65.22
$66.94
50-Day Range
$65.00
$73.13
52-Week Range
$52.43
$73.85
Volume
2,665 shs
Average Volume
262,556 shs
Market Capitalization
$3.70 billion
P/E Ratio
86.28
Dividend Yield
N/A
Beta
1.13
30 days | 90 days | 365 days | Advanced Chart
Receive MMSI News and Ratings via Email

Sign-up to receive the latest news and ratings for Merit Medical Systems and its competitors with MarketBeat's FREE daily newsletter.


Merit Medical Systems logo

About Merit Medical Systems

Merit Medical Systems, Inc. engages in the manufacture and marketing of proprietary disposable medical devices. It operates through the Cardiovascular and Endoscopy segments. The Cardiovascular segment consists of peripheral intervention, cardiac intervention, interventional oncology and spine, and cardiovascular and critical care product groups. The Endoscopy segment integrates non-vascular stent technology with balloon dilators, inflation devices, guide wires, procedure kits, and other devices that are used by gastroenterologists, endoscopists, pulmonologists, and thoracic and general surgeons. The company was founded by Fred P. Lampropoulos, Darla Gill, Kent W. Stanger, and William Padilla in July 1987 and is headquartered in South Jordan, UT.

Headlines

Merit Medical Systems (NASDAQ:MMSI) Shares Gap Down to $69.46
November 8, 2021 |  americanbankingnews.com
PDCO vs. MMSI: Which Stock Is the Better Value Option?
October 6, 2021 |  finance.yahoo.com
3 Promising MedTech Stocks to Snap Up in Second-Half 2021
September 23, 2021 |  finance.yahoo.com
See More Headlines

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
Health Care Supplies
Sector
Medical
Current Symbol
NASDAQ:MMSI
CUSIP
58988910
Employees
5,989
Year Founded
1987

Sales & Book Value

Annual Sales
$963.88 million
Cash Flow
$3.46 per share
Book Value
$17.95 per share

Profitability

Net Income
$-9.84 million
Pretax Margin
4.46%

Debt

Price-To-Earnings

Miscellaneous

Free Float
54,369,000
Market Cap
$3.70 billion
Optionable
Optionable

Company Calendar

Last Earnings
10/28/2021
Today
11/29/2021
Fiscal Year End
12/31/2021
Next Earnings (Estimated)
2/23/2022

Social Links


MarketRank

Overall MarketRank

2.17 out of 5 stars

Medical Sector

405th out of 1,392 stocks

Surgical & Medical Instruments Industry

42nd out of 125 stocks

Analyst Opinion: 2.4Community Rank: 4.7Dividend Strength: 0.0Insider Behavior: 2.5Valuation: 1.3 5 -4 -3 -2 -1 -












Merit Medical Systems (NASDAQ:MMSI) Frequently Asked Questions

Is Merit Medical Systems a buy right now?

6 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Merit Medical Systems in the last year. There are currently 1 hold rating and 5 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" Merit Medical Systems stock.
View analyst ratings for Merit Medical Systems
or view top-rated stocks.

How has Merit Medical Systems' stock price been impacted by COVID-19?

Merit Medical Systems' stock was trading at $32.88 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, MMSI shares have increased by 99.4% and is now trading at $65.57.
View which stocks have been most impacted by COVID-19
.

Are investors shorting Merit Medical Systems?

Merit Medical Systems saw a decline in short interest during the month of October. As of October 29th, there was short interest totaling 1,190,000 shares, a decline of 24.2% from the October 14th total of 1,570,000 shares. Based on an average trading volume of 254,700 shares, the short-interest ratio is currently 4.7 days. Approximately 2.2% of the company's shares are sold short.
View Merit Medical Systems' Short Interest
.

When is Merit Medical Systems' next earnings date?

Merit Medical Systems is scheduled to release its next quarterly earnings announcement on Wednesday, February 23rd 2022.
View our earnings forecast for Merit Medical Systems
.

How were Merit Medical Systems' earnings last quarter?

Merit Medical Systems, Inc. (NASDAQ:MMSI) posted its quarterly earnings data on Thursday, October, 28th. The medical instruments supplier reported $0.52 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.44 by $0.08. The medical instruments supplier earned $267.02 million during the quarter, compared to analysts' expectations of $260.61 million. Merit Medical Systems had a trailing twelve-month return on equity of 12.81% and a net margin of 4.10%. The company's quarterly revenue was up 9.4% compared to the same quarter last year. During the same quarter last year, the business earned $0.42 earnings per share.
View Merit Medical Systems' earnings history
.

What guidance has Merit Medical Systems issued on next quarter's earnings?

Merit Medical Systems updated its FY 2021 earnings guidance on Tuesday, November, 23rd. The company provided EPS guidance of $2.070-$2.220 for the period, compared to the Thomson Reuters consensus estimate of $2.170. The company issued revenue guidance of $1.06 billion-$1.07 billion, compared to the consensus revenue estimate of $1.07 billion.

What price target have analysts set for MMSI?

6 analysts have issued twelve-month price objectives for Merit Medical Systems' shares. Their forecasts range from $71.00 to $83.00. On average, they anticipate Merit Medical Systems' share price to reach $76.50 in the next year. This suggests a possible upside of 16.7% from the stock's current price.
View analysts' price targets for Merit Medical Systems
or view top-rated stocks among Wall Street analysts.

Who are Merit Medical Systems' key executives?

Merit Medical Systems' management team includes the following people:
  • Fred P. Lampropoulos, Chairman, President & Chief Executive Officer
  • Ronald A. Frost, Chief Operating Officer (LinkedIn Profile)
  • Raul Parra, Chief Financial Officer & Treasurer
  • Joseph Pierce, Chief Information Officer
  • Jason Treft, Chief Technology Officer

What is Fred P. Lampropoulos' approval rating as Merit Medical Systems' CEO?

158 employees have rated Merit Medical Systems CEO Fred P. Lampropoulos on Glassdoor.com. Fred P. Lampropoulos has an approval rating of 73% among Merit Medical Systems' employees.

What other stocks do shareholders of Merit Medical Systems own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Merit Medical Systems investors own include Citigroup (C), OraSure Technologies (OSUR), LightPath Technologies (LPTH), Overstock.com (OSTK), EXFO (EXFO), Energy Transfer (ET), RTI Surgical (RTIX), NVIDIA (NVDA), Under Armour (UA) and Advanced Micro Devices (AMD).

What is Merit Medical Systems' stock symbol?

Merit Medical Systems trades on the NASDAQ under the ticker symbol "MMSI."

Who are Merit Medical Systems' major shareholders?

Merit Medical Systems' stock is owned by a number of retail and institutional investors. Top institutional investors include BlackRock Inc. (13.37%), ArrowMark Colorado Holdings LLC (6.47%), Starboard Value LP (6.29%), William Blair Investment Management LLC (6.01%), Conestoga Capital Advisors LLC (4.25%) and Dimensional Fund Advisors LP (2.95%). Company insiders that own Merit Medical Systems stock include A Scott Anderson, Brian G Lloyd, David Floyd, David Ming-Teh Liu, Franklin J Miller, Fred P Lampropoulos, Jill Anderson, Joseph Wright, Lynne Ward, Nolan E Karras, Raul Jr Parra and Ronald Frost.
View institutional ownership trends for Merit Medical Systems
.

Which institutional investors are selling Merit Medical Systems stock?

MMSI stock was sold by a variety of institutional investors in the last quarter, including ArrowMark Colorado Holdings LLC, Balyasny Asset Management LLC, Starboard Value LP, William Blair Investment Management LLC, The Manufacturers Life Insurance Company , WCM Investment Management LLC, Arrowstreet Capital Limited Partnership, and Invesco Ltd.. Company insiders that have sold Merit Medical Systems company stock in the last year include A Scott Anderson, Brian G Lloyd, Fred P Lampropoulos, Jill Anderson, Joseph Wright, Lynne Ward, Raul Jr Parra, and Ronald Frost.
View insider buying and selling activity for Merit Medical Systems
or view top insider-selling stocks.

Which institutional investors are buying Merit Medical Systems stock?

MMSI stock was bought by a variety of institutional investors in the last quarter, including Fuller & Thaler Asset Management Inc., New York State Common Retirement Fund, Ziegler Capital Management LLC, Point72 Asset Management L.P., Emerald Mutual Fund Advisers Trust, Crestline Management LP, Emerald Advisers LLC, and Calamos Advisors LLC.
View insider buying and selling activity for Merit Medical Systems
or or view top insider-buying stocks.

How do I buy shares of Merit Medical Systems?

Shares of MMSI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Merit Medical Systems' stock price today?

One share of MMSI stock can currently be purchased for approximately $65.57.

How much money does Merit Medical Systems make?

Merit Medical Systems has a market capitalization of $3.70 billion and generates $963.88 million in revenue each year. The medical instruments supplier earns $-9.84 million in net income (profit) each year or $0.76 on an earnings per share basis.

How many employees does Merit Medical Systems have?

Merit Medical Systems employs 5,989 workers across the globe.

Does Merit Medical Systems have any subsidiaries?

The following companies are subsidiares of Merit Medical Systems: Alveolus Inc., Argon Medical Devices Netherlands BV, BSMD Ventures Inc., BioSphere Medical Inc., BioSphere Medical Japan Inc., BioSphere Medical SA, Brightwater Medical Inc., Brightwater Medical Inc., Cianna Medical Inc., DFINE Inc., Dfine Europe GmbH, Fibrovein Holdings Limited, ITL Healthcare Pty Ltd., IntelliMedical Technologies Pty Ltd., LLC Merit Technologies, Merit Holdings Inc., Merit Maquiladora México S. DE R.L. DE C.V., Merit Medical (NRI) Ireland Limited, Merit Medical Africa (Pty) LTD, Merit Medical Asia Company Limited, Merit Medical Australia Pty Ltd., Merit Medical Austria GmbH, Merit Medical Beijing Co. Ltd., Merit Medical Belgium Sprl, Merit Medical Canada Ltd., Merit Medical Coatings B.V., Merit Medical Comercialização Distribuição Importação e Exportação de Produtos Hospitalares LTDA., Merit Medical Denmark A/S, Merit Medical Egypt LLC, Merit Medical Finland Ltd., Merit Medical France SAS, Merit Medical GmbH, Merit Medical Ireland Ltd., Merit Medical Italy S.R.L., Merit Medical Japan KK, Merit Medical Korea Co. Ltd., Merit Medical ME FZ-LLC, Merit Medical Malaysia Sdn. Bhd, Merit Medical Nederland B.V., Merit Medical New Zealand Limited, Merit Medical Norway AS, Merit Medical Portugal S.A., Merit Medical Singapore Holdings Pte. Ltd, Merit Medical Singapore Pte. Ltd., Merit Medical South Africa (Pty) LTD, Merit Medical Spain S.L.Unipersonal, Merit Medical Switzerland AG, Merit Medical Systems AB, Merit Medical Systems India Private Limited, Merit Medical System’s NRI Limited, Merit Medical Turkey Tıbbi Ürünler Ticaret Anonim Şirketi, Merit Medical UK Limited, Merit Mexico Sales S. de R.L. de C.V., Merit Sensor Systems Inc., STD Pharmaceutical (Ireland) Limited, STD Pharmaceutical Products Limited, Thomas Medical Products Inc., Vascular Access Technologies Inc., and Vascular Insights LLC.

When was Merit Medical Systems founded?

Merit Medical Systems was founded in 1987.

What is Merit Medical Systems' official website?

The official website for Merit Medical Systems is www.merit.com.

Where are Merit Medical Systems' headquarters?

Merit Medical Systems is headquartered at 1600 WEST MERIT PARK WAY, SOUTH JORDAN UT, 84095.

How can I contact Merit Medical Systems?

Merit Medical Systems' mailing address is 1600 WEST MERIT PARK WAY, SOUTH JORDAN UT, 84095. The medical instruments supplier can be reached via phone at (801) 253-1600, via email at [email protected], or via fax at 801-253-1652.


This page was last updated on 11/29/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.